Skip to main content
Join The Community

Investing, Stocks, Stocks to Buy, Videos

Novo Nordisk’s Big Comeback: Why Analysts Are Turning Bullish Again

By Rick Orford · November 4, 2025

Novo Nordisk (NYSE: NVO) just faced a 54% collapse, but its groundbreaking CagriSema drug and $5.2B Akero acquisition could reignite growth. The pipeline looks strong, Wall Street is turning bullish again, and the leadership shake-up may be the setup for a stunning recovery.

Stock prices used were the market prices of Oct. 28, 2025. The video was published on Nov. 3, 2025. On the date of publication, Rick Orford did not have (either directly or indirectly) positions in any of the securities mentioned in this video.

Watch the latest stock breakdowns on YouTube

New videos on stocks, options income and dividends from Rick Orford. Subscribe so you never miss one.